Although minor numerical differences in ECOG performance status distribution were observed, these differences did not reach statistical significance.
← all excerpts
Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide.
1
—
—